0001104659-22-071895.txt : 20220616 0001104659-22-071895.hdr.sgml : 20220616 20220616161149 ACCESSION NUMBER: 0001104659-22-071895 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220614 FILED AS OF DATE: 20220616 DATE AS OF CHANGE: 20220616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHWARTZ BRIAN CENTRAL INDEX KEY: 0001431322 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 221020681 MAIL ADDRESS: STREET 1: C/O ARQULE, INC. STREET 2: 1 WALL STREET, 6TH FLOOR CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 4 1 tm2218645-3_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-14 0 0001130166 Cyclacel Pharmaceuticals, Inc. CYCC 0001431322 SCHWARTZ BRIAN C/O CYCLACEL PHARMACEUTICALS, INC., 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922 1 0 0 0 Common Stock 2022-06-14 4 A 0 15822 0 A 19383 D Stock Option (right to buy) 1.11 2022-06-14 4 A 0 31645 0 A 2023-06-14 2032-06-14 Common Stock 31645 31645 D The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023. These options were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. /s/ Brian Schwartz 2022-06-16